Methamphetamine and Other Substance Use During Pregnancy: Preliminary Estimates From the Infant Development, Environment, and Lifestyle (IDEAL) Study
Authors:
- 5 January 2006
- journal article
- research article
- Published by Springer Nature in Maternal and Child Health Journal
- Vol. 10 (3) , 293-302
Abstract
Objectives: Methamphetamine use is a continuing problem in several regions of the United States and yet few studies have focused on prenatal methamphetamine exposure. The purpose of this study was to estimate the prevalence and correlates of alcohol, tobacco, and other substance use—including methamphetamine—during pregnancy. Methods: The sample consisted of the first 1632 eligible mothers who consented to participate in a large-scale multisite study focused on prenatal methamphetamine exposure. This unselected screening sample included both users and nonusers of alcohol, tobacco, methamphetamine, and other drugs. Substance use was determined by maternal self-report and/or GC/MS confirmation of a positive meconium screen. Results: Overall, 5.2% of women used methamphetamine at some point during their pregnancy. One quarter of the sample smoked tobacco, 22.8% drank alcohol, 6.0% used marijuana, and 1.3% used barbiturates prenatally. Less than 1% of the sample used heroin, benzodiazapenes, and hallucinogens. Multivariate modeling results showed that tobacco smokers and illicit drug users were more likely to be single and less educated, have attended less than 11 prenatal visits, and utilize public financial assistance. Conclusions: This is the first large-scale investigation to report the prevalence of methamphetamine use during pregnancy in areas of the United States where methamphetamine is a notable concern. Follow-up research is ongoing to investigate the outcomes associated with prenatal methamphetamine exposure. Given that this research extends and confirms previous findings showing that high-risk groups of pregnant women can be identified on the basis of basic demographic characteristics, targeted interventions are greatly needed to reduce serious adverse outcomes associated with prenatal alcohol and tobacco use.Keywords
This publication has 44 references indexed in Scilit:
- Compliance with prenatal care visits in substance abusersThe Journal of Maternal-Fetal & Neonatal Medicine, 2003
- Amphetamine addiction during pregnancy: 14‐year follow‐up of growth and school performanceActa Paediatrica, 1996
- DEVELOPMENTAL NEUROTOXICITY TO METHAMPHETAMINESClinical and Experimental Pharmacology and Physiology, 1995
- Prenatal methamphetamine attenuates serotonin mediated renin secretion in male and female rat progeny: Evidence for selective long‐term dysfunction of serotonin pathways in brainSynapse, 1993
- Treatment Programming for Alcohol and Drug-Dependent Pregnant WomenInternational Journal of the Addictions, 1993
- 2-2) Behavioral Teratogenicity of MethamphetamineThe Journal of Toxicological Sciences, 1991
- Echoencephalographic findings in neonates assciiated with maternal cocaine and methamphetamine use: Incidence and clinical correlatesThe Journal of Pediatrics, 1989
- Perinatal cocaine and methamphetamine exposure: Maternal and neonatal correlatesThe Journal of Pediatrics, 1987
- Pre‐school Children of Amphetamine‐addicted Mothers: I. Somatic and Psychomotor DevelopmentActa Paediatrica, 1985
- AMPHETAMINE ADDICTION AND PREGNANCYActa Paediatrica, 1980